Unravelling Peptic Ulcers: Comprehensive Insights into Etiology, Diagnosis, Screening Techniques, and Treatment
- PMID: 39318209
- DOI: 10.2174/0113816128310979240828102727
Unravelling Peptic Ulcers: Comprehensive Insights into Etiology, Diagnosis, Screening Techniques, and Treatment
Abstract
The risk of illnesses is increasing in the modern era due to unhealthy and modern lifestyles. Research has shown that the most frequent acid-induced abrasion, which often occurs in the stomach and proximal duodenum, is gastric and peptic ulcer disease (PUD), which is a primary worldwide health concern. The deformity is characterized by denuded mucosa and spreads into the submucosa. Non-steroidal antiinflammatory drugs (NSAIDs) and H. pylori infections are two common offenders. In the past, it has been thought that dietary variables, stress, and an acidic hypersecretory state encourage mucosal disruption in peptic acid disease patients. Peptic ulcers continue to be a significant health issue because of their potential for substantial consequences, including bleeding, blockage, and perforation, even with advancements in detection and treatment. This review discusses current screening methods for peptic ulcers and the challenges in diagnosis and treatment, emphasizing the need for precise diagnosis and more effective therapies.
Keywords: Helicobacter pylori; Ulcer models; epidemiology; inhibators; peptic ulcer; screening techniques..
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
Eradication of Helicobacter pylori for prevention of aspirin-associated peptic ulcer bleeding in adults over 65 years: the HEAT RCT.Health Technol Assess. 2025 Aug;29(42):1-62. doi: 10.3310/LLKF7871. Health Technol Assess. 2025. PMID: 40844182 Clinical Trial.
-
H. pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer.Cochrane Database Syst Rev. 2004;(2):CD004062. doi: 10.1002/14651858.CD004062.pub2. Cochrane Database Syst Rev. 2004. PMID: 15106235
-
H. pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer.Cochrane Database Syst Rev. 2003;(4):CD004062. doi: 10.1002/14651858.CD004062. Cochrane Database Syst Rev. 2003. Update in: Cochrane Database Syst Rev. 2004;(2):CD004062. doi: 10.1002/14651858.CD004062.pub2. PMID: 14584003 Updated.
-
Eradication therapy for peptic ulcer disease in Helicobacter pylori-positive people.Cochrane Database Syst Rev. 2016 Apr 19;4(4):CD003840. doi: 10.1002/14651858.CD003840.pub5. Cochrane Database Syst Rev. 2016. PMID: 27092708 Free PMC article.
-
Prescription of Controlled Substances: Benefits and Risks.2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
Cited by
-
Pharmaceutical Science Strategies for Drug Therapeutic Advancement: Drug Discovery and Development (Part 2).Curr Pharm Des. 2025;31(26):2063-2064. doi: 10.2174/0113816128411718250513102548. Curr Pharm Des. 2025. PMID: 40855805 No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous